Work

Figure 1 from Impact of Glucocorticoids on Immune Checkpoint Inhibitor Efficacy and Circulating Biomarkers in Non–Small Cell Lung Cancer Patients

Year: 2025

Type: other

Abstract: The use of corticosteroids at the initiation of ICI therapy correlates with decreased ORR and worse prognosis in patients with NSCLC. A–D, ORR, PFS, and OS of patients at RPCCC (A and C) and USC (B and D) treated with ICI therapy on the basis of baseline steroid use. The ORR was analyzed by the Fisher exact test. P values for PFF and OS were calculated by a log-rank (Mantel–Cox) test. mOS, median OS; mPFS, median PFS.

DOI: 10.1158/2767-9764.29492946

Authors: Lauren Polyakov, Angelina Lim, Alexandra Meyer, Aubree Mades, Joshua Ni, Ryan Cooper, Shirley Ye, Ryutaro Kajihara, Takaaki Oba, Leslie Contreras, Eihab Abdelfatah, Joy Sarkar, Junko Matsuzaki, Ming Li, Rajeev Sharma, Brahm H. Segal, Robert C. Hsu, Hongbin Chen, Jorge Nieva, Fumito Ito

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4412087590

Cites:

Cited by:

Related to: 10